Skip to main content
. 2022 Oct 11;50(8):1110–1124. doi: 10.1002/jcu.23265

FIGURE 4.

FIGURE 4

Pathophysiology of CRS‐4. Interaction between heart and kidney in cardiorenal syndrome type 4. Ca, calcium; EPO, erythropoietin; LVH, left ventricular hypertrophy; PBUTs, protein‐bound uremic toxins; Phos, phosphorus; RAAS, renin‐angiotensin‐aldosterone system; SNS, sympathetic nervous system